Dr. Reddy's Laboratories (DRREDDY) — Financial Results

Dr. Reddy's Laboratories reported Q3 FY2026 consolidated total income of ₹5,398 lakhs, with net profit after tax of ₹579 lakhs. Standalone results showed similar metrics: ₹5,398 lakhs revenue and ₹579 lakhs net profit. For the nine-month period ended December 31, 2025, consolidated total income reached ₹15,148 lakhs with net profit after tax of ₹1,500 lakhs. The company's board recommended an interim dividend of ₹20 per share (200% on face value). Basic EPS for Q3 stood at ₹28.95 on standalone basis.

📄 View Original Announcement (PDF)

📊 Stock Analysis — DRREDDY ✨ Ask AI About This

About Dr. Reddy's Laboratories Limited (DRREDDY)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹1,11,568.6 Cr P/E: 20.0 ROE: 16.6% ROCE: 19.7%

View full DRREDDY stock details →

📡 Get AI alerts when DRREDDY files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track DRREDDY — Free

💡 Ask AI about this filing

"How does this financial results affect Dr. Reddy's Laboratories Limited's outlook?" "What did Dr. Reddy's Laboratories Limited announce on 22 January 2026?" "Is this positive or negative for DRREDDY?"

Ask AI Free →

📊 More DRREDDY filings

See all DRREDDY filings →

🔥 Also filed on 22 January 2026

ICICIBANK ICICI Bank Limited Financial Results HDFCLIFE HDFC Life Insurance Company Limited Financial Results HINDPETRO Hindustan Petroleum Corporation Limited Financial Results RELIANCE Reliance Industries Limited Announcement POLYCAB Polycab India Limited Financial Results PAGEIND Page Industries Limited Financial Results

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when DRREDDY files new disclosures

Track DRREDDY filings, board meetings, and corporate actions. Free email alerts at 5 PM.